![]() |
市場調查報告書
商品編碼
2032473
電子資料收集系統市場報告:按產品、組件、發展階段、最終用戶和地區分類(2026-2034 年)Electronic Data Capture Systems Market Report by Delivery Mode, Component, Development Phase, End User, and Region 2026-2034 |
||||||
全球電子數據採集(EDC)系統市場在2025年達到15億美元。展望未來,IMARC Group預測,到2034年,該市場將達到35億美元,2026年至2034年的複合年成長率(CAGR)為9.32%。臨床試驗的快速數位化、雲端系統的日益普及以及行動EDC的出現是推動市場成長的主要因素。
電子資料收集 (EDC) 系統是指用於以電子方式收集和管理臨床試驗資料的軟體工具。這些系統收集的數據範圍廣泛,包括患者人口統計資訊、病歷、不利事件、實驗室結果、臨床療效評估、電子知情同意書 (eConsent) 以及研究中心資訊。 EDC 系統被監管機構、臨床試驗申辦者、合約研究組織 (CRO)、試驗參與者和資料管理人員廣泛使用。 EDC 系統有助於提高資料擷取效率、提升資料品質、最大限度地減少人為錯誤、保護機密資訊並降低資料遺失或重複的風險。此外,EDC 系統還能提高臨床試驗的效率,提供即時監測功能,支援決策制定,並確保數據的準確性、可靠性和一致性。
全球臨床試驗的快速數位化是推動市場成長的主要因素之一。電子資料收集 (EDC) 系統被廣泛用於自動化臨床試驗的各項任務,例如資料收集、儲存、監測和分析,從而加快流程、提高透明度、預防錯誤並提升整體效率。此外,糖尿病、高血壓、阿茲海默症、多發性硬化症和心血管疾病 (CVD) 等慢性疾病盛行率的不斷上升,也推動了對新型治療方法方法的需求,這也是市場成長的因素之一。此外,成本效益高、易於使用、擴充性、高度安全且能提供即時數據存取的雲端系統的日益普及,也促進了市場成長。同時,行動 EDC 的普及,利用智慧型手機和平板電腦便捷且經濟高效地採集患者數據,從而提高患者參與度、改善依從性並降低錯誤風險,同樣推動了市場成長。此外,機器學習 (ML) 和人工智慧 (AI) 的融合,在提升數據分析能力、加速決策以及識別模式、趨勢和異常方面,正積極推動市場成長。同時,政府對臨床試驗資料安全性和完整性的嚴格監管,也增加了對先進資料管理和報告系統(例如電子資料收集系統 (EDC))的需求,以更好地滿足監管機構的要求。其他有望推動市場成長的因素還包括:對個人化醫療日益成長的需求、廣泛的研發活動以及對以患者為中心的臨床試驗的日益重視。
The global electronic data capture (EDC) systems market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.32% during 2026-2034. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease , multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.